Improving the monitoring of Kaposi sarcoma treatment using advanced imaging technology.
PRecision IMaging to Evaluate Kaposi Sarcoma (PRIME-KS)
This study is testing a new tool called SkinScan3D to help doctors better track how well treatments are working for people with Kaposi sarcoma, especially in places where healthcare can be challenging, so patients can get the best care possible.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10951388 on NIH RePORTER |
What this research studies
This research focuses on enhancing the monitoring of treatment responses for Kaposi sarcoma (KS) through the use of a new technology called SkinScan3D (SS3D). The current methods for assessing KS lesions are often subjective and can lead to prolonged treatment and unnecessary side effects, especially in low- and middle-income countries. By implementing SS3D, which utilizes liquid lens technology and artificial intelligence, the research aims to provide a more objective and efficient way to monitor KS lesions, ultimately improving patient care in regions where it is most needed.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Kaposi sarcoma, particularly those receiving treatment in low- and middle-income countries.
Not a fit: Patients who do not have Kaposi sarcoma or those receiving treatment in high-income countries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely monitoring of Kaposi sarcoma treatment, reducing unnecessary side effects and improving patient outcomes.
How similar studies have performed: Other research has shown promise in using advanced imaging technologies for cancer monitoring, suggesting that this approach could be effective.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Odeny, Thomas — Washington University
- Study coordinator: Odeny, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.